Invasiveness versus resolution in BCIs
Synchron
The real competitive fight is shifting from least invasive surgery to the best balance of surgical simplicity and signal quality. Synchron wins by threading a 16 electrode Stentrode through a blood vessel, so hospitals can use catheter based workflows instead of open brain surgery. Precision is pushing into the middle, with a cortical surface film inserted through a micro slit that still avoids penetrating brain tissue, while aiming for 1,024 electrodes and much denser signal capture.
-
Synchron is built for interventional access. Its device is delivered through the jugular vein and expanded against the vessel wall near motor cortex, which lowers procedural intensity but leaves the electrodes separated from brain tissue by the vessel wall, limiting how much signal it can capture compared with surface arrays.
-
Precision is built for resolution. Layer 7 sits directly on the cortex, uses a cranial micro slit under 1 mm, and packages 1,024 electrodes into a film about one fifth the thickness of a human hair. That gives it far more spatial detail for decoding intent, while still avoiding needles pushed into brain tissue.
-
This creates a clear three way ladder in BCIs. Synchron sits at the low invasiveness end, Precision targets the middle with minimally invasive cortical placement, and Neuralink represents the highest bandwidth but most procedurally complex model with implanted threads placed into the brain by a surgical robot.
Going forward, the market is likely to reward the company that can make higher channel count BCIs feel routine inside existing hospital workflows. If Precision can keep its procedure simple while proving better control than endovascular systems, it puts direct pressure on Synchron's core positioning as the safest practical path to useful everyday brain computer interfaces.